Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism

    loading  Checking for direct PDF access through Ovid



We have shown that American women with polycystic ovary syndrome (PCOS) have decreased glucose-stimulated release of a putative mediator of insulin action, D-chiro-inositol (DCI)-containing inositolphosphoglycan (DCI-IPG), and increased urinary clearance of DCI (uClDCI), which was associated with hyperinsulinemia.


DCI levels and the release of insulin and DCI-IPG during an oral glucose tolerance test (AUCs) were assessed in 27 Greek PCOS and 10 normal Greek women.


PCOS women were heavier than controls (BMI=28.4 versus 23.7 kg/m2, P=0.05) with higher waist-to-hip ratios (WHR=0.78 versus 0.71, P=0.009) and increased free testosterone (P=0.048) and AUCinsulin (P=0.04). In PCOS women, incremental AUCDCI-IPG was significantly decreased by 59% (2158 versus 5276%·min, P=0.01), even after correction for BMI and WHR. Finally, increased uClDCI (r=0.35, P=0.04) and decreased AUCDCI-IPG (r=0.46, P=0.004) were significantly associated with hyperinsulinemia in all women together, even after correction for BMI and WHR (Ps=0.02 and 0.007), and regardless of PCOS status.


Greek women, with or without PCOS, display increased uClDCI and decreased AUCDCI-IPG in association with higher insulin levels but independent of adiposity. Increased clearance of inositols might reduce tissue availability of DCI and decrease the release of DCI-IPG mediator, which could contribute to insulin resistance and compensatory hyperinsulinemia in Greek women, as previously described in American women.

Related Topics

    loading  Loading Related Articles